product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
PHD-2/Egln1 Antibody
catalog :
3293
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; loading ...; fig 5e
Oh E, Kim J, Kim J, Kim S, Lee J, Hong S, et al. NQO1 inhibits proteasome-mediated degradation of HIF-1?. Nat Commun. 2016;7:13593 pubmed publisher
  • western blot; mouse; fig 1
Shin J, Nunomiya A, Kitajima Y, Dan T, Miyata T, Nagatomi R. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway. Skelet Muscle. 2016;6:5 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 4c
Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, et al. The LINK-A lncRNA activates normoxic HIF1? signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18:213-24 pubmed publisher
Kozlova N, Wottawa M, Katschinski D, Kristiansen G, Kietzmann T. Hypoxia-inducible factor prolyl hydroxylase 2 (PHD2) is a direct regulator of epidermal growth factor receptor (EGFR) signaling in breast cancer. Oncotarget. 2017;8:9885-9898 pubmed publisher
product information
SKU :
3293S
Product-Name :
PHD-2/Egln1 Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
Developmental Biology
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
50
Host :
Rabbit
Target :
PHD-2 (Egln1)
Primary-Protein :
EGLN1
Alt-Names :
C1orf12,DKFZp761F179,ECYT3,EGLN1,Egl nine homolog 1,HIF prolyl hydroxylase 2,HIF-PH2,HIF-prolyl hydroxylase 2,HIFPH2,HPH-2,HPH2,Hypoxia-inducible factor prolyl hydroxylase 2,PHD2,Prolyl hydroxylase domain-containing protein 2,SM-20,SM20,ZMYND6,egl nine homolog 1 (C. elegans),egl nine-like protein 1,zinc finger MYND domain-containing protein 6
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.